Kyowa Hakko USA has announced that it will be taking part in the Complementary Medicines Australia (CMA) Innovation Day 2026 in Sydney, Australia, later this month.
The company said it will spotlight the growing relevance of cognitive health in the Australian supplement market at the show.
CMA Innovation Day is a leading annual event in Australia for the complementary medicines supply chain, bringing together ingredient suppliers, brand owners, formulators and retail buyers.
Attendees can explore the latest innovations in vitamins, minerals and supplements across Australia and the Asia-Pacific region.
With the rising consumer demand for cognitive support, science-backed ingredients are essential for next-generation supplement formulations.
Chief Operating Officer and Vice President of Scientific and Regulatory Affairs, Dr Danielle Citrolo, will host a session titled "Cognizin: Premium Citicoline for Cognitive Performance and Long-Term Brain Health" at the show.
The presentation will examine the science behind Cognizin and how it supports cognitive health through multiple complementary mechanisms.
Notably, Cognizin is the only citicoline ingredient to hold status with the Australian Therapeutic Goods Administration (TGA), reflecting the rigorous quality and safety standards that have made it a trusted choice for global partners in the nutraceutical and wellness sectors.
"Cognitive health is a rapidly growing priority for Australian consumers and the brands that serve them," said Dr Citrolo.
This presentation will give attendees a clear picture of the science behind Cognizin and why it represents a premium, differentiated ingredient for any brain health product strategy.
Speaking exclusively to Nutraceutical Business Review, Karen Todd, VP of Global Brand Marketing for Kyowa Hakko USA, added: "Australia is one of the most dynamic and discerning markets for cognitive health innovation in the Asia-Pacific region and consumers want to understand what they are putting in their bodies and why it works."
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.